Works matching IS 15228517 AND DT 2024 AND VI 26 AND IP 12
Results: 26
"Splice of Life": How RNA is Rewriting the Meningioma Story.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 12, p. 2237, doi. 10.1093/neuonc/noae194
- By:
- Publication type:
- Article
Erratum to: The biological significance of tumor grade, age, enhancement, and extent of resection in IDH-mutant gliomas: How should they inform treatment decisions in the era of IDH inhibitors?
- Published in:
- 2024
- Publication type:
- Correction Notice
Response to the letter by Wang et al.: Selumetinib for plexiform neurofibroma: Advances and ongoing challenges.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 12, p. 2394, doi. 10.1093/neuonc/noae181
- By:
- Publication type:
- Article
Erratum to: Defining neuroblastoma: from origin to precision medicine.
- Published in:
- 2024
- Publication type:
- Correction Notice
Trastuzumab deruxtecan: Defining a novel systemic treatment standard for HER2-positive breast cancer brain metastases?
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 12, p. 2157, doi. 10.1093/neuonc/noae202
- By:
- Publication type:
- Article
Forthcoming Meetings.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 12, p. 2399, doi. 10.1093/neuonc/noae212
- Publication type:
- Article
Corrigendum to: Executive summary of the American Radium Society appropriate use criteria for brain metastases in epidermal growth factor receptor mutated-mutated and ALK-fusion non-small cell lung cancer.
- Published in:
- 2024
- Publication type:
- Correction Notice
Selumetinib for plexiform neurofibroma: advances and ongoing challenges.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 12, p. 2391, doi. 10.1093/neuonc/noae180
- By:
- Publication type:
- Article
Intracranial administration of anti-PD-1 and anti-CTLA-4 immune checkpoint-blocking monoclonal antibodies in patients with recurrent high-grade glioma.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 12, p. 2208, doi. 10.1093/neuonc/noae177
- By:
- Publication type:
- Article
MGMT promoter methylation and survival following chemotherapy for WHO grade 4 IDH-mutant astrocytoma.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 12, p. 2388, doi. 10.1093/neuonc/noae157
- By:
- Publication type:
- Article
Corrigendum to: "Ras-mediated modulation of pyruvate dehydrogenase activity regulates mitochondrial reserve capacity and contributes to glioblastoma tumorigenesis".
- Published in:
- 2024
- Publication type:
- Correction Notice
Defective autophagy of pericytes enhances radiation-induced senescence promoting radiation brain injury.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 12, p. 2288, doi. 10.1093/neuonc/noae153
- By:
- Publication type:
- Article
Defining neuroblastoma: From origin to precision medicine.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 12, p. 2174, doi. 10.1093/neuonc/noae152
- By:
- Publication type:
- Article
RNA splicing as a biomarker and phenotypic driver of meningioma DNA-methylation groups.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 12, p. 2222, doi. 10.1093/neuonc/noae150
- By:
- Publication type:
- Article
Interferon regulatory factor 8-driven reprogramming of the immune microenvironment enhances antitumor adaptive immunity and reduces immunosuppression in murine glioblastoma.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 12, p. 2272, doi. 10.1093/neuonc/noae149
- By:
- Publication type:
- Article
A low level of tumor necrosis factor α in tumor microenvironment maintains the self-renewal of glioma stem cells by Vasorin-mediated glycolysis.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 12, p. 2256, doi. 10.1093/neuonc/noae147
- By:
- Publication type:
- Article
Enhancing prognostication and treatment response evaluation in primary CNS lymphoma with <sup>18</sup>F-FDG-PET/CT.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 12, p. 2377, doi. 10.1093/neuonc/noae146
- By:
- Publication type:
- Article
SNO-EANO-EURACAN consensus on management of pineal parenchymal tumors.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 12, p. 2159, doi. 10.1093/neuonc/noae128
- By:
- Publication type:
- Article
Final outcome analysis from the phase II TUXEDO-1 trial of trastuzumab-deruxtecan in HER2-positive breast cancer patients with active brain metastases.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 12, p. 2305, doi. 10.1093/neuonc/noae123
- By:
- Publication type:
- Article
Safety and efficacy of selumetinib in pediatric and adult patients with neurofibromatosis type 1 and plexiform neurofibroma.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 12, p. 2352, doi. 10.1093/neuonc/noae121
- By:
- Publication type:
- Article
A comparative analysis of IDH-mutant glioma in pediatric, young adult, and older adult patients.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 12, p. 2364, doi. 10.1093/neuonc/noae142
- By:
- Publication type:
- Article
BMScope: A scoping review to chart the evolving clinical study landscape in brain and leptomeningeal metastasis.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 12, p. 2193, doi. 10.1093/neuonc/noae140
- By:
- Publication type:
- Article
Immune landscape of isocitrate dehydrogenase-stratified primary and recurrent human gliomas.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 12, p. 2239, doi. 10.1093/neuonc/noae139
- By:
- Publication type:
- Article
Osimertinib-induced DNA resistance mutations in cerebrospinal fluid of epidermal growth factor receptor-mutated non-small-cell lung carcinoma patients developing leptomeningeal metastases: Osimertinib Resistance Analysis-leptomeningeal metastases study.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 12, p. 2316, doi. 10.1093/neuonc/noae138
- By:
- Publication type:
- Article
Risk of new tumor, carotid stenosis, and stroke after stereotactic radiosurgery for pituitary tumor: A multicenter study of 2254 patients with imaging follow-up.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 12, p. 2328, doi. 10.1093/neuonc/noae133
- By:
- Publication type:
- Article
Maternal obesogenic diet operates at the tumor cell of origin to increase incidence and decrease latency of neurofibromatosis type 1 optic pathway glioma.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 12, p. 2339, doi. 10.1093/neuonc/noae136
- By:
- Publication type:
- Article